One Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

One Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,587	Closed	-$315K	–	559
2025 Q4	$315K	Buy	+2,587	New	+$297K	0.01%	446
2024 Q2	–	Sell	-7,634	Closed	-$724K	–	384
2024 Q1	$724K	Buy	+7,634	New	+$708K	0.03%	199
2022 Q4	–	Sell	-37,380	Closed	-$2.96M	–	314
2022 Q3	$2.96M	Buy	+37,380	New	+$3.15M	0.18%	115

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

One Capital Management's XBI Position: Q1 2026 in Review

One Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,587 shares — an estimated $315K sold.

One Capital Management first reported a position in XBI in Q3 2022 and held it in 3 quarters. The position peaked at $2.96M in Q3 2022. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

One Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
One Capital Management sold 2,587 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $315K.
One Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 3 quarters.
One Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.96M in Q3 2022.
816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.